Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
101M
-
Number of holders
-
1
-
Total 13F shares, excl. options
-
15K
-
Shares change
-
-33M
-
Total reported value, excl. options
-
$79.5K
-
Value change
-
-$10.1M
-
Number of buys
-
1
-
Number of sells
-
-51
-
Price
-
$5.30
Significant Holders of FIBROGEN INC - Common Stock, $0.01 par value (FGEN) as of Q2 2025
56 filings reported holding FGEN - FIBROGEN INC - Common Stock, $0.01 par value as of Q2 2025.
FIBROGEN INC - Common Stock, $0.01 par value (FGEN) has 1 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 15K shares
of 101M outstanding shares and own 0.01% of the company stock.
Largest 10 shareholders include Connective Capital Management, LLC (15K shares), US BANCORP \DE\ (0 shares), NJ State Employees Deferred Compensation Plan (0 shares), Vanguard Personalized Indexing Management, LLC (0 shares), R Squared Ltd (0 shares), Savvy Advisors, Inc. (0 shares), GFG Capital, LLC (0 shares), COMMONWEALTH EQUITY SERVICES, LLC (0 shares), SouthState Corp (0 shares), and FRANKLIN STREET ADVISORS INC /NC (0 shares).
This table shows the top 1 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.